Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00477906
Status:
UNKNOWN
Last Update Posted:
2015-12-03
First Post:
2007-05-22
Brief Title:
M-Vax Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage IV Melanoma
Sponsor:
AVAX Technologies
Organization:
AVAX Technologies
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07
Start Date Type:
None
Primary Completion Date:
2019-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-01
Completion Date Type:
ESTIMATED
First Submit Date:
2007-05-22
First Submit QC Date:
May 22 2007
Study First Post Date:
2007-05-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-12-02
Last Update Post Date:
2015-12-03
Last Update Post Date Type:
ESTIMATED